Skip to main content

Table 3 Biochemical parameters at admission

From: A single-oral bolus of 100,000 IU of cholecalciferol at hospital admission did not improve outcomes in the COVID-19 disease: the COVID-VIT-D—a randomised multicentre international clinical trial

 

Cholecalciferol group

Control group

n

n=274

n

n=269

Laboratory parameters

 Calcidiol (ng/mL), median [IQR]

273

17.0 [11.8, 22.0]

265

16.1 [11.5, 22.0]

 Creatinine (mg/dL), median [IQR]

269

0.9 [0.8, 1.1]

257

0.9 [0.8, 1.1]

 CRP (mg/dL), median [IQR]

241

10.1 [4.4, 37.7]

239

8.9 [3.3, 25.9]

 Albumin (g/L), median [IQR]

154

38.0 [34.3, 40.0]

146

39.0 [36.0, 41.0]

 Haemoglobin (g/dL), median [IQR]

270

13.8 [12.9, 14.5]

262

14.0 [13.0, 14.9]

 LDH (U/L), median [IQR]

229

382.0 [265.0, 491.0]

215

345.0 [244.5, 457.5]

 Leucocytes (No./μL), median [IQR]

270

7.0 [5.4, 9.4]

262

7.0 [5.1, 8.8]

 Interleukin-6 (pg/mL), median [IQR]

97

13.0 [6.0, 30.0]

93

11.0 [3.7, 25.7]

 Ferritin (ng/mL), median [IQR]

229

750.0 [390.0, 1500.0]

220

587.5 [305.8, 1126.0]

 Calcium (mg/dL), median [IQR]

204

8.8 [8.4, 9.2]

192

8.9 [8.5, 9.2]

 Phosphate (mg/dL), median [IQR]

161

3.3 [2.8, 3.9]

151

3.2 [2.7, 3.8]

  1. n number of patients available for analysis, IQR interquartile range, CRP C-reactive protein, LDH Lactate dehydrogenase